238 related articles for article (PubMed ID: 28012766)
41. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases.
Dell'Oglio P; Larcher A; Muttin F; Di Trapani E; Trevisani F; Ripa F; Carenzi C; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
Urol Oncol; 2017 Nov; 35(11):662.e9-662.e15. PubMed ID: 28801027
[TBL] [Abstract][Full Text] [Related]
42. Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis.
Kokorovic A; Breau RH; Kapoor A; Finelli A; So AI; Lavallee LT; Tanguay S; Pouliot F; Drachenberg DE; Fairey A; Lattouf JB; Kawakami J; Wood L; Mallick R; Rendon RA
Urol Oncol; 2021 Jun; 39(6):371.e17-371.e25. PubMed ID: 33785219
[TBL] [Abstract][Full Text] [Related]
43. [Results of radical nephrectomy associated with regional lymphadenectomy for renal cell carcinoma].
Igarashi T; Murakami S; Hara S; Tanaka M; Oki T; Isaka S; Okano T; Abe K; Shimazaki J; Matsuzaki O
Hinyokika Kiyo; 1991 Sep; 37(9):975-80. PubMed ID: 1785423
[TBL] [Abstract][Full Text] [Related]
44. Radical nephrectomy.
Marshall FF
Urology; 1995 Aug; 46(2):153-4. PubMed ID: 7624985
[No Abstract] [Full Text] [Related]
45. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
Whitson JM; Meng M
BJU Int; 2014 Jan; 113(1):2-3. PubMed ID: 24330055
[No Abstract] [Full Text] [Related]
46. Inflammatory myofibroblastic tumor of the kidney.
Jenkins LC; Whittington E; Ciancio G; Jorda M
J Urol; 2013 Jun; 189(6):2310-1. PubMed ID: 23507397
[No Abstract] [Full Text] [Related]
47. [Is surgery useful in kidney cancer with lymph node invasion?].
Li GR; Ludot T; Armand C; Castro R; Versini P; Legon C; Tostain J
Ann Urol (Paris); 1997; 31(3):151-4. PubMed ID: 9251831
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
Belldegrun A; Tsui KH; deKernion JB; Smith RB
J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
[TBL] [Abstract][Full Text] [Related]
49. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group.
Blom JH; van Poppel H; Marechal JM; Jacqmin D; Sylvester R; Schröder FH; de Prijck L
Eur Urol; 1999 Dec; 36(6):570-5. PubMed ID: 10559610
[TBL] [Abstract][Full Text] [Related]
50. [Renal cell carcinoma].
Shimazui T; Kawai K; Akaza H
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2073-5. PubMed ID: 15570943
[TBL] [Abstract][Full Text] [Related]
51. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
52. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
53. [Extensive nephrectomy in severe forms of cancer of the kidney in the adult].
Choquenet C; Foldes P; Dufour B
Ann Urol (Paris); 1986; 20(6):427-32. PubMed ID: 3566201
[TBL] [Abstract][Full Text] [Related]
54. Radical surgery for renal-cell carcinoma: caval neoplastic excision, adrenalectomy, lymphadenectomy, adjacent organ resection.
Marshall FF; Steinberg GD; Pound CR; Partin AW
World J Urol; 1995; 13(3):159-62. PubMed ID: 7550387
[TBL] [Abstract][Full Text] [Related]
55. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
56. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute.
Ornellas AA; Andrade DM; Ornellas P; Wisnescky A; Schwindt AB
Int Braz J Urol; 2012; 38(2):185-94. PubMed ID: 22555027
[TBL] [Abstract][Full Text] [Related]
58. [Impact of systematic lymph node dissection in the resection of pulmonary metastases of solid extrapulmonary tumours].
Meimarakis G; Angele MK; Schneider C; Weidenhagen R; Kalaitzis N; Molki A; Jauch KW; Hatz R; Winter H
Zentralbl Chir; 2010 Dec; 135(6):556-63. PubMed ID: 21061238
[TBL] [Abstract][Full Text] [Related]
59. [Venous tumor invasion by renal cell carcinoma. Surgical technique, complications and survival rate].
Gschwend J; Maier S; Flohr P; de Petriconi R; Hautmann RE
Urologe A; 1994 Sep; 33(5):440-6. PubMed ID: 7974934
[TBL] [Abstract][Full Text] [Related]
60. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract.
Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
Urology; 2007 Feb; 69(2):265-9. PubMed ID: 17320661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
